Department of Medicine, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden.
J Natl Cancer Inst. 2010 Apr 21;102(8):557-67. doi: 10.1093/jnci/djq043. Epub 2010 Feb 24.
Chronic immune stimulation appears to be associated with lymphoplasmacytic lymphoma (LPL)-Waldenström macroglobulinemia (WM); however, available information is sparse. We conducted, to our knowledge, the most comprehensive study to date to evaluate associations between a personal or family history of many immune-related and/or inflammatory disorders and the subsequent risk of LPL-WM.
We used Swedish population-based registries to identify 2470 case patients with LPL-WM, 9698 matched control subjects, and almost 30 000 first-degree relatives of either case patients or control subjects. We evaluated a wide range of autoimmune, infectious, allergic, and inflammatory conditions. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) for each condition by use of logistic regression.
An increased risk of LPL-WM was associated with a personal history of the following autoimmune diseases: systemic sclerosis (OR = 4.7, 95% CI = 1.4 to 15.3), Sjögren syndrome (OR = 12.1, 95% CI = 3.3 to 45.0), autoimmune hemolytic anemia (OR = 24.2, 95% CI = 5.4 to 108.2), polymyalgia rheumatica (OR = 2.9, 95% CI = 1.6 to 5.2), and giant cell arteritis (OR = 8.3, 95% CI = 2.1 to 33.1). An increased risk of LPL-WM was associated with a personal history of the following infectious diseases: pneumonia (OR = 1.4, 95% CI = 1.1 to 1.7), septicemia (OR = 2.4, 95% CI = 1.2 to 4.3), pyelonephritis (OR = 1.7, 95% CI = 1.1 to 2.5), sinusitis (OR = 2.7, 95% CI = 1.4 to 4.9), herpes zoster (OR = 3.4, 95% CI = 2.0 to 5.6), and influenza (OR = 2.9, 95% CI = 1.7 to 5.0). An increased risk of LPL-WM was associated with a family history of the following autoimmune or infectious diseases: Sjögren syndrome (OR = 5.0, 95% CI = 2.1 to 12.0), autoimmune hemolytic anemia (OR = 3.8, 95% CI = 1.1 to 13.2), Guillain-Barré syndrome (OR = 4.1, 95% CI = 1.8 to 9.4), cytomegalovirus (OR = 2.7, 95% CI = 1.4 to 5.3), gingivitis and periodontitis (OR = 1.9, 95% CI = 1.3 to 2.7), and chronic prostatitis (OR = 4.3, 95% CI = 1.7 to 11.1).
Personal history of certain immune-related and/or infectious conditions was strongly associated with increased risk of LPL-WM. The association of both personal and family history of Sjögren syndrome and autoimmune hemolytic anemia with risk of LPL-WM indicates the potential for shared susceptibility for these conditions.
慢性免疫刺激似乎与淋巴浆细胞淋巴瘤(LPL)-瓦尔登斯特伦巨球蛋白血症(WM)有关;然而,现有的信息还很有限。我们进行了迄今为止最全面的研究,以评估许多与免疫相关和/或炎症相关的疾病的个人或家族史与随后发生 LPL-WM 的风险之间的关系。
我们使用瑞典基于人群的登记处来确定 2470 例 LPL-WM 病例患者、9698 名匹配的对照患者以及几乎 30000 名病例患者或对照患者的一级亲属。我们评估了广泛的自身免疫、感染、过敏和炎症疾病。我们使用逻辑回归计算了每种疾病的比值比(OR)和 95%置信区间(CI)。
LPL-WM 的风险增加与以下自身免疫性疾病的个人病史相关:系统性硬化症(OR=4.7,95%CI=1.4 至 15.3)、干燥综合征(OR=12.1,95%CI=3.3 至 45.0)、自身免疫性溶血性贫血(OR=24.2,95%CI=5.4 至 108.2)、巨细胞性多肌炎(OR=2.9,95%CI=1.6 至 5.2)和巨细胞动脉炎(OR=8.3,95%CI=2.1 至 33.1)。LPL-WM 的风险增加与以下传染病的个人病史相关:肺炎(OR=1.4,95%CI=1.1 至 1.7)、败血症(OR=2.4,95%CI=1.2 至 4.3)、肾盂肾炎(OR=1.7,95%CI=1.1 至 2.5)、鼻窦炎(OR=2.7,95%CI=1.4 至 4.9)、带状疱疹(OR=3.4,95%CI=2.0 至 5.6)和流感(OR=2.9,95%CI=1.7 至 5.0)。LPL-WM 的风险增加与以下自身免疫或传染病的家族史相关:干燥综合征(OR=5.0,95%CI=2.1 至 12.0)、自身免疫性溶血性贫血(OR=3.8,95%CI=1.1 至 13.2)、格林-巴利综合征(OR=4.1,95%CI=1.8 至 9.4)、巨细胞病毒(OR=2.7,95%CI=1.4 至 5.3)、牙龈炎和牙周炎(OR=1.9,95%CI=1.3 至 2.7)和慢性前列腺炎(OR=4.3,95%CI=1.7 至 11.1)。
某些与免疫相关和/或感染相关的疾病的个人史与 LPL-WM 的风险增加密切相关。干燥综合征和自身免疫性溶血性贫血的个人和家族史与 LPL-WM 风险之间的关联表明,这些疾病可能存在共同的易感性。